An Act To Amend Title 29 Of The Delaware Code Relating To Reverse Auctions.
Summary
SB 134, as substituted, updates Delaware’s procurement code to modernize and clarify the definition of a “reverse auction.” The bill defines reverse auctioning as an online, real-time electronic bidding process in which vendor prices are visible to participants without revealing vendor identities, and bidders can continue lowering their prices during the auction period. It also expands the definition to include professional services, not just goods and nonprofessional services, when used in the procurement context described by the bill.
The bill creates a specific reverse-auction authority for the State Employee Benefits Committee, but only for procuring professional services for or related to pharmaceuticals or pharmacy benefits management services. Before using a reverse auction, the committee must determine it is advantageous, obtain written approval, adopt written procedures, require vendor preregistration and vetting, and disclose the intended auction process in the solicitation. The bill also allows the committee or procuring agency to hire a third-party vendor to run the auction and requires that vendor names and addresses be recorded. Proposal materials remain confidential until a signed contract is executed, after which they become publicly available under existing procurement disclosure rules.
Impact
The bill amends Title 29, Chapter 69 of the Delaware Code, specifically the state procurement provisions administered by the Section of Government Support Services in the Office of Management and Budget. It changes the statutory definition of reverse auction and adds a new section authorizing reverse auctions for a narrow category of professional services tied to pharmaceuticals and pharmacy benefits management for the State Employee Benefits Committee. The measure affects procurement procedures, vendor registration and disclosure requirements, public-records timing for proposals, and the committee’s ability to use third-party auction platforms.
Sentiment
The voting record shows strong bipartisan support and no recorded opposition, with unanimous passage in both chambers (17-0 in the Senate and 40-0 in the House). The substitute bill appears to have been viewed as a technical modernization of procurement law rather than a controversial policy shift. The absence of committee transcripts limits insight into debate, but the final votes suggest broad agreement on the need to update and clarify the reverse-auction framework.
Contention
The main policy distinction in the substitute version is that it narrows the practical use of reverse auctions to procurement of professional services related to pharmaceuticals or pharmacy benefits management services, rather than broadly authorizing them for all professional services. Potential points of concern, though not reflected in recorded opposition, would likely include whether reverse auctions are appropriate for professional services, how vendor confidentiality is balanced against transparency, and whether the preregistration and vetting requirements are sufficient to ensure responsible bidding. The bill also raises administrative questions about the use of third-party auction vendors and the timing of public access to proposal materials.